Skip to main content
. 2024 Oct 1;50:202. doi: 10.1186/s13052-024-01706-w

Table 2.

Summary of subgroup analysis for the pooled prevalence of treatment failure among HIV-infected children in Sub-Sahara Africa, 2009 to 2023 (n = 33)

Variables Subgroup Prevalence,% (95% CI, I2, P-value)
Country Cameroon 39.41 (21.54–57.28, 96.10, < 0.01)
Ethiopia 13.77 (10.08–17.47, 94.9, < 0.01)
Nigeria 20.66 (12.44–28.88, 78.80, 0.009)
South Africa 16.81 (12.59–21.03, 96, < 0.01)
Tanzania 36.96 (24.15–49.77, 94.50, < 0.01)
Other 39.30 ( 29.91–48.69, 97.80, < 0.01)
Study design Cross-sectional 34.76 (22.44–47.08, 98.60, < 0.01)
Cohort 20.82 (17.02–24.62, 97.70, < 0.01)
Publication year 2009–2015 27.87 (22.30–33.45, 97.90, < 0.01)
2016–2023 25.29 (18.25–32.33, 98.90, < 0.01)
HHS Vulnerability Disclosure